MDD is associated with a low-grade systemic inflammatory profile, with consistently reported increases in IL-6, CRP, and, in many studies, TNF-α, which correlates with symptom severity and treatment resistance [139,140]. This evidence concerns the gene CRP and major depressive disorder.